PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
49.12%
Net income growth under 50% of VET's 162.72%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-100.00%
Both reduce yoy D&A, with VET at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-79.38%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-100.00%
Negative yoy SBC while VET is 266.11%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
1185.19%
Slight usage while VET is negative at -402.55%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
7.94%
AR growth of 7.94% while VET is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
100.00%
AP growth of 100.00% while VET is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
26.41%
Some yoy usage while VET is negative at -402.55%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
1749.16%
Well above VET's 77.07%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
1.38%
Some CFO growth while VET is negative at -49.48%. John Neff would note a short-term liquidity lead over the competitor.
12.29%
Lower CapEx growth vs. VET's 98.51%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
100.00%
Acquisition spending well above VET's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
238.11%
We have some outflow growth while VET is negative at -286.10%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
18.24%
Investing outflow well above VET's 4.70%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-86.82%
We cut debt repayment yoy while VET is 72.65%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
11.41%
Buyback growth at 75-90% of VET's 13.85%. Bill Ackman would call for more share repurchases if undervaluation is evident, to match competitor’s approach.